Skip to content

Clinical molecular subtyping study based on precision Fusobacterium detection in colrectal cancer.

Clinical molecular subtyping study based on precision Fusobacterium detection in colrectal cancer.

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037022
Enrollment
Unknown
Registered
2020-08-26
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

CRC group:Nil
Healthy control group:Nil

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1. Aged over 18 years; 2. Clinically diagnosed as colorectal cancer; 3. No severe diseases in heart, liver, kidney and other organs; 4. Willing to cooperate in sample collection.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. The patient were also accompanied with multiple organ tumors or severe uncontrolled medical disease or acute infection; 3. Patients dont understand the purpose of this study or dont agree with requirements for the study; 4. Patients who lack of legal capacity or limitation of legal capacity; 5. Patients who are not willing to cooperate in sample collection; 6. Patients who have related medical history which could interfere results and increase risk of patients.

Design outcomes

Primary

MeasureTime frame
Identification of clostridium species ;

Countries

China

Contacts

Public ContactQing Wei

Shanghai Tenth People's Hospital

weiqing1971@aliyun.com+86 18917689343

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026